News
Latest News and Press Releases
Axcelead DDP Signs an Agreement with Astellas for HT-ADMET Studies
Fujisawa, Japan, December 11, 2025 – Axcelead Drug Discovery Partners, Inc. (President & CEO: Kengo Okada, Ph.D.;...
Research Article on Exon Skipping in Alport Syndrome Mouse Model Published in Scientific Reports
Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of...
Research article on pharmacological evaluation using a MASH mouse model has been published in Scientific Reports
Differences between Therapeutic Mechanisms of Resmetirom and Semaglutide against MASH in Western Diet-Fed MC4R-Knockout Mice Publication Published...
Axcelead DDP Enters into Contract Research Agreement with RealizeEdge Partners for the Creation of Candidate Compounds Targeting Specific Proteins
Fujisawa, Japan, November 11, 2025 – Axcelead Drug Discovery Partners, Inc. (Head Office: Fujisawa City, Kanagawa Prefecture;...
xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery
Kyoto and Kanagawa, Japan, September 18, 2025 – xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery...